LifePoint Health (LPNT) Earning Positive Press Coverage, Report Finds
News coverage about LifePoint Health (NASDAQ:LPNT) has been trending positive on Wednesday, Accern reports. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. LifePoint Health earned a media sentiment score of 0.45 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.5716330643274 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment’s rankings:
- Zacks Investment Research Downgrades LifePoint Health, Inc. (LPNT) to Sell (americanbankingnews.com)
- BidaskClub Upgrades Valero Energy Partners LP (VLP) to “Sell” (fishinghd.com)
- Reviewing Tenet Healthcare Corporation (THC) & LifePoint Health (LPNT) (americanbankingnews.com)
- Zacks: Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Announce Quarterly Sales of $1.60 Billion (americanbankingnews.com)
- Financial Contrast: American Renal Associates Holdings (ARA) and LifePoint Health (LPNT) (americanbankingnews.com)
LPNT has been the topic of several recent research reports. Morgan Stanley initiated coverage on LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target on the stock. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $73.00 to $74.00 in a report on Tuesday, June 6th. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a report on Tuesday, July 4th. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a report on Wednesday, July 5th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $66.18.
LifePoint Health (NASDAQ:LPNT) opened at 56.15 on Wednesday. The company has a market cap of $2.25 billion, a price-to-earnings ratio of 12.57 and a beta of 0.86. The stock has a 50 day moving average price of $60.77 and a 200-day moving average price of $62.61. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. LifePoint Health’s revenue was up .2% compared to the same quarter last year. During the same period last year, the company posted $0.69 earnings per share. On average, analysts predict that LifePoint Health will post $4.07 EPS for the current fiscal year.
In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of LifePoint Health stock in a transaction on Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman William F. Carpenter III sold 82,347 shares of LifePoint Health stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now directly owns 504,535 shares in the company, valued at $32,365,920.25. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “LifePoint Health (LPNT) Earning Positive Press Coverage, Report Finds” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/08/30/lifepoint-health-lpnt-earning-positive-press-coverage-report-finds.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.